Ahmed Hamdy M.D., Chief Executive Officer at Vincerx Pharma, Inc. (VINC), bought 15,660 shares at $12.77 ($200K) on 2021-06-29, disclosed to the SEC on 2021-06-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.77 | 7,830 | $100K | 50.0% |
| 2 | $12.77 | 7,830 | $100K | 50.0% |
| Total | $12.77 avg | 15,660 | $200K | 100% |
| Filing → |
| VINC | BUY | 2022-06-27 | $34K | — | Filing → |
| VINC | BUY | 2021-12-27 | $65K | — | Filing → |
| PCYC | SELL | 2010-10-07 | $123K | — | Filing → |